VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
-4.13%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$122M
AUM Growth
+$122M
(+15%)
Cap. Flow
+$27M
Cap. Flow
% of AUM
22.11%
Top 10 Holdings %
Top 10 Hldgs %
78.8%
Holding
34
New
4
Increased
4
Reduced
4
Closed
6
Top Buys
| 1 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$37M |
| 2 |
Inspire Medical Systems
INSP
|
$3.04M |
| 3 |
Heron Therapeutics
HRTX
|
$2.56M |
| 4 |
Gossamer Bio
GOSS
|
$2.55M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$1.9M |
Top Sells
| 1 |
ADMA Biologics
ADMA
|
$3.54M |
| 2 |
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
|
$3.12M |
| 3 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$3.11M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$2.17M |
| 5 |
89bio
ETNB
|
$1.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALIM
1
DELISTED
Alimera Sciences, Inc.
ALIM
| $42.2M | 34.02% | 13,608,533 +11,948,879 | +720% | +$37M |
|
2
Praxis Precision Medicines
PRAX
$958M
| $8.87M | 7.15% | 5,185,000 | – | – |
|
3
Jasper Therapeutics
JSPR
$45.5M
| $7.59M | 6.12% | 11,219,036 | – | – |
|
|
4
Heron Therapeutics
HRTX
$207M
| $7.2M | 5.8% | 6,986,744 +2,486,744 | +55% | +$2.56M |
|
|
5
ADMA Biologics
ADMA
$4.12B
| $6.22M | 5.01% | 1,736,100 -989,951 | -36% | -$3.54M |
|
6
TELA Bio
TELA
$70.5M
| $5.97M | 4.81% | 746,087 | – | – |
|
|
QIPT
7
Quipt Home Medical
QIPT
$114M
| $5.6M | 4.52% | 1,100,000 +130,000 | +13% | +$662K |
|
8
Lantheus
LNTH
$3.73B
| $5.21M | 4.2% | 75,000 -25,000 | -25% | -$1.74M |
|
|
OPTN
9
DELISTED
OptiNose
OPTN
| $4.42M | 3.57% | 3,596,861 | – | – |
|
10
MoonLake Immunotherapeutics
MLTX
$3.54B
| $3.15M | 2.54% | 55,300 | – | – |
|
|
11
Inspire Medical Systems
INSP
$2.77B
| $3.04M | 2.45% | +15,300 | New | +$3.04M |
|
|
IMGN
12
DELISTED
Immunogen Inc
IMGN
| $3.01M | 2.43% | 189,500 | – | – |
|
13
InspireMD
NSPR
$102M
| $2.96M | 2.38% | 904,029 | – | – |
|
|
14
Gossamer Bio
GOSS
$562M
| $2.55M | 2.06% | +3,065,136 | New | +$2.55M |
|
15
Cabaletta Bio
CABA
$133M
| $2.28M | 1.84% | 150,000 -100,000 | -40% | -$1.52M |
|
|
16
Apellis Pharmaceuticals
APLS
$3.48B
| $1.9M | 1.53% | +50,000 | New | +$1.9M |
|
17
Geron
GERN
$893M
| $1.65M | 1.33% | 778,500 | – | – |
|
18
Tenet Healthcare
THC
$16.3B
| $1.64M | 1.33% | 24,937 -26,963 | -52% | -$1.78M |
|
|
ICVX
19
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $1.24M | 1% | 160,630 | – | – |
|
|
ASLN
20
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $1.18M | 0.95% | +625,000 | New | +$1.18M |
|
21
Annexon
ANNX
$226M
| $1.09M | 0.88% | 459,746 | – | – |
|
22
Edesa Biotech
EDSA
$16.3M
| $810K | 0.65% | 1,281,615 | – | – |
|
23
Cullinan Oncology
CGEM
$445M
| $679K | 0.55% | 75,000 +25,000 | +50% | +$226K |
|
24
InflaRx
IFRX
$108M
| $596K | 0.48% | 200,000 | – | – |
|
25
Rezolute
RZLT
$619M
| $528K | 0.43% | 400,000 | – | – |
|